Sheryl L. Conley

CIK: 0001238659

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ANIK

Anika Therapeutics, Inc.

Director

STIM

Neuronetics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ANIK
Anika Therapeutics, Inc.
Jun 18, 2026
Award(A)
Direct
10.4K shares-
STIM
Neuronetics, Inc.
May 28, 2026
Award(A)
Direct
30K shares-
STIM
Neuronetics, Inc.
Oct 20, 2025
Award(A)
Direct
7.3K shares-
ANIK
Anika Therapeutics, Inc.
Jun 20, 2025
Award(A)
Direct
14.2K shares-
STIM
Neuronetics, Inc.
May 22, 2025
Award(A)
Direct
30K shares-
STIM
Neuronetics, Inc.
Feb 7, 2025
Other(J)
Direct
44.4K shares at avg. $2.25$100K

		Type	Shares	Price		Ownership
Jun 18, 2026	ANIK Anika Therapeutics, Inc.	Award(A)	10,402	-	$0	Direct
May 28, 2026	STIM Neuronetics, Inc.	Award(A)	30,000	-	$0	Direct
Oct 20, 2025	STIM Neuronetics, Inc.	Award(A)	7,326	-	-	Direct
Jun 20, 2025	ANIK Anika Therapeutics, Inc.	Award(A)	14,164	-	-	Direct
May 22, 2025	STIM Neuronetics, Inc.	Award(A)	30,000	-	-	Direct
Feb 7, 2025	STIM Neuronetics, Inc.	Other(J)	44,444	$2.25	$99,999	Direct

1-6 of 6 transactions

About CONLEY SHERYL L

CONLEY SHERYL L (SEC CIK 0001238659) files insider reports with the SEC as Director of Anika Therapeutics, Inc. (ANIK) and Director of Neuronetics, Inc. (STIM).

Signal8 holds 6 ownership filings by CONLEY SHERYL L, all Form 4s, filed between Feb 10, 2025 and Jun 23, 2026. Those filings report 6 transactions, from Feb 7, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on CONLEY SHERYL L's filings is in BEDFORD, MA.

Recent filings by CONLEY SHERYL L

Jun 18, 2026: Grant or award of ANIK shares (Form 4, code A).
May 28, 2026: Grant or award of STIM shares (Form 4, code A).
Oct 20, 2025: Grant or award of STIM shares (Form 4, code A).
Jun 20, 2025: Grant or award of ANIK shares (Form 4, code A).
May 22, 2025: Grant or award of STIM shares (Form 4, code A).

Other insiders filing for Anika Therapeutics, Inc. (ANIK)

Fischetti Gary P, Director
HENNEMAN JOHN B III, Director
Richard Stephen, Director
Capper Joseph H, Director
Griffin Stephen D., President and CEO
McLeod Ian, SVP, CAO & Treasurer

How to read Form 4 transaction codes